Platform
Company
Immunology & Autoimmune
Review status
Currently under review
Pending specialist review and validation.
This test measures the relative amounts of two forms of coproporphyrin, called isomers III and I, in a urine sample and reports their ratio. Coproporphyrins are small molecules made during heme production, and their pattern in urine reflects how the liver processes and excretes these compounds into bile.
Clinicians use this ratio to help differentiate inherited conditions that affect bilirubin and organic anion transport in the liver, such as Dubin-Johnson and Rotor syndromes, from acquired problems with bile flow. The ratio can also shift with cholestasis, other liver diseases, and some porphyrin metabolism disorders. The specimen is typically collected as a random urine sample, protected from light, and handled promptly to preserve accuracy.
When you have persistent jaundice, dark urine, or abnormal liver tests, your clinician may order this test to clarify whether the pattern points toward an inherited transporter condition or a problem with bile flow due to medications, inflammation, or obstruction. In the context of suspected porphyria, it can complement other porphyrin and precursor tests to refine the diagnosis.
Understanding the pattern helps guide next steps, such as repeating testing with careful light protection, measuring total and fractionated porphyrins, checking porphobilinogen and aminolevulinic acid, reviewing medications, or considering genetic evaluation. Knowing the likely cause can prevent unnecessary procedures and focus care on monitoring, lifestyle adjustments, or targeted therapy.
Your result will be interpreted alongside your symptoms, liver blood tests, and other porphyrin studies. A lower than expected ratio may fit the pattern seen in certain inherited transporter conditions, while a higher than expected ratio can occur with cholestasis or some porphyrin disorders. Because many factors can shift this measurement, one result is rarely diagnostic on its own.
If results point to a specific cause, your clinician may suggest confirmatory tests, such as genetic testing for hereditary conjugated hyperbilirubinemia, imaging to look at bile ducts, or additional porphyrin studies. If results are borderline or unexpected, repeating the test with strict light protection and reviewing medications and alcohol exposure can be helpful. Most findings can be managed without urgency, but you should seek care promptly if you develop severe abdominal pain, fever, or worsening jaundice.
Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.
Coproporphyrins degrade with light and improper storage, which can alter the measured isomer pattern. Shield the urine from light and deliver it to the lab quickly.
Drugs that affect liver transport or bile flow, such as rifampin, probenecid, anabolic steroids, or cholestyramine, and alcohol use can shift the ratio. Always list current medications and supplements.
Any condition that slows bile flow, including hepatitis, cholestasis from stones or strictures, or inflammation, can change the isomer distribution and the reported ratio.
Very dilute or very concentrated urine may influence measured porphyrin fractions. Follow collection instructions and avoid extreme fluid intake before testing.
Normal patterns can differ in children, and pregnancy can alter bile flow and transport, which may affect interpretation. Tell your clinician if you are pregnant.
Intercurrent illness, fever, or prolonged fasting can modify porphyrin metabolism and biliary excretion, leading to temporary changes in the ratio.
References